LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 2,440 pages found matching data breach- Putnam Investments to Settle 401k Self-Dealing Lawsuit for $12.5 Million
May-6-20 Boston, MA Participants in the Putnam Retirement Plan have agreed to settle their ERISA lawsuit against Putnam Investments and other Plan fiduciaries for $12.5 million and certain prospective changes in plan administration. Following close on the heels of the U.S. Supreme Court’s decision not to review the lower court’s determination, the s... - Sen. McCaskill Probes Anthem Emergency Room Coverage Denials
Jul-28-18 Washington, DC On July 17, 2018 Sen. Claire McCaskill’s office released a report detailing the results of an investigation into Anthem Blue Cross Blue Shield’s efforts to cut costs by denying emergency room coverage after the fact. Many of these insurance claim denials were eventually reversed. But Anthem may have succeeded in its overall goal... - Defective Hip Implant Lawsuit News and Legal Information
Hip replacement lawsuits have been filed due to early failure of certain hip implants used in the procedure. Metal-on-metal hip replacement systems have reportedly caused pain and other side effects, often requiring revision surgery. Defective hip implant lawsuits have been filed against various manufacturers and distributors by patients alleging hip replac... - Another Option for Workers Who Cannot Save through an ERISA Retirement Plan
Feb-8-24 San Francisco, CA In February 2022, the United States Supreme Court denied the petition for certiorari filed by the petitioner in Howard Jarvis Taxpayers Association v. The California Secure Choice Retirement Savings Program (CalSavers) . The denial kept in place a decision of the Ninth Circuit that permitted a California-sponsored and adminis... - Medtronic Lawsuit Plaintiffs Earn Relief from Special Appeals Court
Nov-8-14 Annapolis, MD The plaintiffs in a Medtronic lawsuit may have faced stormy seas when a trial court dismissed various claims against the manufacturer of the Medtronic Infuse bone graft. However, when a Special Appeals Court reviewed the case within the framework of the Medical Device Amendments Act of 1976 (MDA) and the various nuances of the framework t... - More Ranitidine Cancer Concerns Lead to Zantac Lawsuits
Jan-9-20 Santa Clara, CA Since the FDA last September reported that minute amounts of a carcinogen called N-nitrosodimethylamine (NDMA) was detected in Zantac, along with several other heartburn medications, a number of Zantac cancer lawsuits have followed. The FDA and Zantac Despite voluntary recalls from manufacturers (including Sanofi and Glenmark... - FDA Warns of Risk of Oral Birth Defects in Children Born to Mothers Taking Topiramate
Mar-4-11 Washington, DC Data from the North American Antiepileptic Drug (AED) Pregnancy Registry indicate an increased risk of oral clefts in infants exposed to Topamax (topiramate) during the first trimester of pregnancy. Infants exposed to topiramate as a single therapy experienced a 1.4 percent prevalence of oral clefts, compared with a prevalence of 0.38 pe... - Will Ketek Manufacturer Escape Liability?
Feb-23-11 New York, NY A recent decision by the United States District Court in the Eastern District of New York has ruled against class-action status in a lawsuit by plaintiffs against Sanofi-Aventis, the manufacturer of Ketek . The latter is an antibiotic that was brought to market under questionable circumstances and was found to be harmful, with 53 reported c... - Defendant 'Grateful' for Credit Union Overdraft Fee Lawsuit
Dec-13-19 Denver, CO Ent Credit Union has agreed to settle a class action credit union lawsuit concerning excessive overdraft fees . Its CEO has issued an apology and promises to refund all identified NSF fees and overdrafts. Here is what Ent CEO Chad Graves said, “We are truly sorry for the inconvenience this has caused our members and are grateful to both... - Tracking Systems in the U.K Key to Care for Hip Implant Patients, But Non-Existent in the U.S.
Jan-26-18 Santa Cruz, CA: The study, published in the Bone & Joint Journal , finds that the rate of metal-on-metal (MoM) hip implant patients undergoing revision has increased over time. Researchers at the Universities of Oxford and Bristol have suggested the observed differences are in part due to increased patient surveillance . In the U.S., patient sur... - Johnson & Johnson Strikes Back
Apr-5-24 Trenton, NJ On March 27, District Court Judge Michael Shipp issued a brief order that permits J&J to contest scientific evidence linking talc products to ovarian cancer. The ruling could seriously disrupt the 53,796 talcum powder lawsuits that have been consolidated in the District Court for the District of New Jersey. The order cites recent... - Kohl TCPA Violations Lawsuit News and Legal Information
Kohl’s department store is facing allegations that it violates the Telephone Consumer Protection Act (TCPA) by using an automatic-capable dialer to send unsolicited text messages to plaintiffs and consumers nationwide, even after consumers have withdrawn their consent. Attorneys are investigating complaints of Kohl’s unsolicited messages and may seek to... - Pilgrim’s Pride Settles Out of “Wage-Fixing” Lawsuit
Jul-12-21 Baltimore, MD Pilgrim’s Pride Group, one of many poultry processors/defendants, has agreed to settle out of Jien v. Perdue Farms Inc. for $29 million and an agreement to cooperate against the remaining defendants. Rather than proceeding as an unpaid wages claim , Jien was brought as an antitrust case under the Sherman Act . The Sherman Act prohib... - Cialis Risk for Melanoma Subject of Lawsuits
Santa Clara, CA: The alleged link between Cialis (tadalafil) and melanoma has become the subject of an increasing number of complaints that claim Eli Lilly, the makers of Cialis, failed to warn of the risk. Approved for erectile dysfunction, Cialis is a competitor drug to Viagra, which is also facing lawsuits over the alleged associated risk for... - Latest Pfizer Celebrex Court Ruling 50-50
Sep-11-06 San Francisco, CA According to Pfizer, Celebrex is still selling like hot cakes with worldwide sales totalling $471 million ($355 million in the US) in the second quarter of 2006, representing growth of 17% over the same period last year. "We continue to expect full-year Celebrex revenues of at least $2 billion, an ambitious target given the ongoing... - Synchrony Bank Lawsuit Information and Legal News
Synchrony Bank has been accused of violating the Telephone Consumer Protection Act and violating the Fair Debt Collection Practices Act (FDCPA). Thousands of people nationwide who received artificial or automatic telephone dialing systems were involved in the Synchrony Bank TCPA Class Action Lawsuit and Synchrony Bank settlement . Since the settl... - Zyprexa and Suicidal Behavior
Zyprexa is used to treat symptoms of schizophrenia and acute bipolar mania. However, Zyprexa has been linked to serious side effects. Reported Zyprexa side effects include an increased risk of suicide, diabetes and stroke. The alleged link between Zyprexa and suicide has been the focus of lawsuits filed against Eli Lilly, maker of Zyprexa. Zy... - Pregabalin (Lyrica) Linked to Increase in Birth Defects
Santa Clara, CA: Data collected by the Swiss Teratogen Information Service, a facility that collects reports of potential harmful effects of drugs, and a subsequent study on the data published in the journal Neurology, reveals that the pain medication pregabalin (Lyrica) may be linked to birth defects. Pregabalin is approved in the US to treat... - Asthma Drugs: No Cause for Asthma Sufferers to Breathe Easy…
May-27-08 Washington, DC It's been two years since the US Food and Drug Administration (FDA) last issued significant data, and updated product labels for asthma drugs Advair, Serevent and Foradil after concerns that the drugs, while lessening the frequency of wheezing attacks, could increase their ultimate severity. There has been little information since. Tha... - FDA Evaluating Risk of Miscarriage with Oral Fluconazole in Pregnancy
Santa Clara, CA: The US Food and Drug Administration (FDA) is evaluating the results of a Danish study that conclude there is a possible increased risk of miscarriage with the use of oral fluconazole (Diflucan) for yeast infections. The FDA is also reviewing additional data and will communicate final conclusions and recommendations when the review is...